Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ovarian Germ Cell Cancer × Bleomycin × Clear all

Phase

Status

Sponsor Class

NIH 2 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 28 Lymphoma 15 Lymphoma, Large B-Cell, Diffuse 5 Vulvar Neoplasms 3 Neoplasms, Germ Cell and Embryonal 3 Lymphoma, Follicular 3 Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large-Cell, Immunoblastic 2 Dendritic Cell Sarcoma, Interdigitating 2 Warts 1 Ulcer 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Skin Neoplasms 1 Seminoma 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Processes 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Neoplastic Processes 1 Neoplasms, Second Primary 1 Neoplasm Metastasis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Intracranial Non-germinomatous Germ Cell Tumor 1 Hemangioma, Capillary 1 Hemangioma 1

Interventions

Filgrastim 4 Carboplatin 4 Thiotepa 3 Peripheral Blood Stem Cell Transplantation 3 Etoposide 3 etoposide phosphate 2 Paclitaxel 2 Ifosfamide 2 Granulocyte Colony-Stimulating Factor 2 Taxes 1 Radiotherapy 1 Microarray Analysis 1 Mesna 1 Melphalan 1 Immunohistochemistry 1 Hematologic Tests 1 Dasatinib 1 Cyproheptadine 1 Cyclophosphamide 1 Cisplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Blotting, Western 1 Bleomycin 1 Arsenic Trioxide 1 Amifostine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02429687 2023-04-25

MOGCT-01

Shandong University

Phase 3 Recruiting

Ovarian Germ Cell Cancer, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡